Edward E Graves

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planning
    E E Graves
    Department of Radiology, University of California, San Francisco 94143, USA
    Med Phys 28:2489-96. 2001
  2. ncbi request reprint A submillimeter resolution fluorescence molecular imaging system for small animal imaging
    Edward E Graves
    Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA
    Med Phys 30:901-11. 2003
  3. ncbi request reprint Fluorescence molecular imaging of small animal tumor models
    E E Graves
    Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
    Curr Mol Med 4:419-30. 2004
  4. ncbi request reprint Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo
    Xiaojuan Li
    Center of Functional and Molecular Imaging and Department of Radiology, University of California, San Francisco, CA 94107, USA
    AJNR Am J Neuroradiol 26:760-9. 2005
  5. ncbi request reprint Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence
    Tracy R McKnight
    Department of Radiology, Biostatistics Core, Comprehensive Cancer Center, University of California, San Francisco 94143, USA
    J Neurosurg 97:794-802. 2002
  6. ncbi request reprint In vivo tomographic imaging of near-infrared fluorescent probes
    Vasilis Ntziachristos
    Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Bldg 149 13th Street 5406, Charlestown, MA 02129 2060, USA
    Mol Imaging 1:82-8. 2002
  7. ncbi request reprint Singular-value analysis and optimization of experimental parameters in fluorescence molecular tomography
    Edward E Graves
    Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Room 5404, Charlestown, Massachusetts 02129, USA
    J Opt Soc Am A Opt Image Sci Vis 21:231-41. 2004
  8. ncbi request reprint Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy
    Andrea Pirzkall
    Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA 94143, USA
    Int J Radiat Oncol Biol Phys 53:1254-64. 2002
  9. pmc Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer
    Viswam S Nair
    Division of Pulmonary and Critical Care Medicine, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA
    Cancer Res 72:3725-34. 2012
  10. ncbi request reprint In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors
    Moritz F Kircher
    Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA
    Cancer Res 63:6838-46. 2003

Detail Information

Publications10

  1. ncbi request reprint Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planning
    E E Graves
    Department of Radiology, University of California, San Francisco 94143, USA
    Med Phys 28:2489-96. 2001
    ..These images were sent via DICOM transfer to the treatment planning workstation. An analysis of the reproducibility of the..
  2. ncbi request reprint A submillimeter resolution fluorescence molecular imaging system for small animal imaging
    Edward E Graves
    Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA
    Med Phys 30:901-11. 2003
    ..Finally, the in vivo imaging capacity is showcased. It is expected that the large dataset collected can enable superior imaging of molecular probes in vivo and improve quantification of fluorescence signatures...
  3. ncbi request reprint Fluorescence molecular imaging of small animal tumor models
    E E Graves
    Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
    Curr Mol Med 4:419-30. 2004
    ..This technique offers the promise of non-invasively quantifying and visualizing specific molecular activity in living subjects in three dimensions...
  4. ncbi request reprint Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo
    Xiaojuan Li
    Center of Functional and Molecular Imaging and Department of Radiology, University of California, San Francisco, CA 94107, USA
    AJNR Am J Neuroradiol 26:760-9. 2005
    ....
  5. ncbi request reprint Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence
    Tracy R McKnight
    Department of Radiology, Biostatistics Core, Comprehensive Cancer Center, University of California, San Francisco 94143, USA
    J Neurosurg 97:794-802. 2002
    ..The information gleaned from the biopsy correlation study was used to test the hypothesis that there is metabolically active tumor in nonenhancing regions of the T2-hyperintense lesion that can be detected using MR spectroscopy...
  6. ncbi request reprint In vivo tomographic imaging of near-infrared fluorescent probes
    Vasilis Ntziachristos
    Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Bldg 149 13th Street 5406, Charlestown, MA 02129 2060, USA
    Mol Imaging 1:82-8. 2002
    ..This validation of FMT with FRI demonstrated the spatial congruence of fluorochrome activation as determined by the two techniques...
  7. ncbi request reprint Singular-value analysis and optimization of experimental parameters in fluorescence molecular tomography
    Edward E Graves
    Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Room 5404, Charlestown, Massachusetts 02129, USA
    J Opt Soc Am A Opt Image Sci Vis 21:231-41. 2004
    ....
  8. ncbi request reprint Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy
    Andrea Pirzkall
    Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA 94143, USA
    Int J Radiat Oncol Biol Phys 53:1254-64. 2002
    ..We performed a study examining the impact MRSI would have on the routine addition of 2-3-cm margins around MRI T2-weighted hyperintensity to generate the treatment planning clinical target volume (CTV) for low-grade gliomas...
  9. pmc Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer
    Viswam S Nair
    Division of Pulmonary and Critical Care Medicine, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA
    Cancer Res 72:3725-34. 2012
    ..Together, our findings suggest that leveraging tumor genomics with an expanded collection of PET-FDG imaging features may enhance our understanding of FDG uptake as an imaging biomarker beyond its association with glycolysis...
  10. ncbi request reprint In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors
    Moritz F Kircher
    Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA
    Cancer Res 63:6838-46. 2003
    ..Together, these results demonstrate that CLIO-HD is uniquely suited for quantitative repetitive MRI of adoptively transferred cells and that this approach may be particularly useful for evaluating novel cell-based therapies in vivo...